Sharmistha Mishra1, Elisa Mountain, Michael Pickles, Peter Vickerman, Suresh Shastri, Charles Gilks, Nandini K Dhingra, Reynold Washington, Marissa L Becker, James F Blanchard, Michel Alary, Marie-Claude Boily. 1. aDepartment of Infectious Disease Epidemiology, Imperial College London bSocial and Mathematical Epidemiology, London School of Hygiene and Tropical Medicine, London, UK cGovernment of Karnataka, Bangalore, India dSchool of Population Health, University of Queensland, Brisbane, Australia eUNAIDS India, New Delhi fKarnataka Health Promotion Trust, Bangalore, India gDepartment of Community Health Sciences, Centre for Global Public Health, University of Manitoba, Winnipeg hCentre de recherche du CHU de Québec, Département de médecine sociale et préventive, Université Laval, Québec City, Québec, Canada. iDivision of Infectious Diseases, St. Michael's Hospital, University of Toronto, Toronto, Canada jSt. John's Medical College Research Institute, Bangalore, India.
Abstract
OBJECTIVE: To compare the potential population-level impact of expanding antiretroviral treatment (ART) in HIV epidemics concentrated among female sex workers (FSWs) and clients, with and without existing condom-based FSW interventions. DESIGN: Mathematical model of heterosexual HIV transmission in south India. METHODS: We simulated HIV epidemics in three districts to assess the 10-year impact of existing ART programs (ART eligibility at CD4 cell count ≤350) beyond that achieved with high condom use, and the incremental benefit of expanding ART by either increasing ART eligibility, improving access to care, or prioritizing ART expansion to FSWs/clients. Impact was estimated in the total population (including FSWs and clients). RESULTS: In the presence of existing condom-based interventions, existing ART programs (medium-to-good coverage) were predicted to avert 11-28% of remaining HIV infections between 2014 and 2024. Increasing eligibility to all risk groups prevented an incremental 1-15% over existing ART programs, compared with 29-53% when maximizing access to all risk groups. If there was no condom-based intervention, and only poor ART coverage, then expanding ART prevented a larger absolute number but a smaller relative fraction of HIV infections for every additional person-year of ART. Across districts and baseline interventions, for every additional person-year of treatment, prioritizing access to FSWs was most efficient (and resource saving), followed by prioritizing access to FSWs and clients. CONCLUSION: The relative and absolute benefit of ART expansion depends on baseline condom use, ART coverage, and epidemic size. In south India, maximizing FSWs' access to care, followed by maximizing clients' access are the most efficient ways to expand ART for HIV prevention, across baseline intervention context.
OBJECTIVE: To compare the potential population-level impact of expanding antiretroviral treatment (ART) in HIV epidemics concentrated among female sex workers (FSWs) and clients, with and without existing condom-based FSW interventions. DESIGN: Mathematical model of heterosexual HIV transmission in south India. METHODS: We simulated HIV epidemics in three districts to assess the 10-year impact of existing ART programs (ART eligibility at CD4 cell count ≤350) beyond that achieved with high condom use, and the incremental benefit of expanding ART by either increasing ART eligibility, improving access to care, or prioritizing ART expansion to FSWs/clients. Impact was estimated in the total population (including FSWs and clients). RESULTS: In the presence of existing condom-based interventions, existing ART programs (medium-to-good coverage) were predicted to avert 11-28% of remaining HIV infections between 2014 and 2024. Increasing eligibility to all risk groups prevented an incremental 1-15% over existing ART programs, compared with 29-53% when maximizing access to all risk groups. If there was no condom-based intervention, and only poor ART coverage, then expanding ART prevented a larger absolute number but a smaller relative fraction of HIV infections for every additional person-year of ART. Across districts and baseline interventions, for every additional person-year of treatment, prioritizing access to FSWs was most efficient (and resource saving), followed by prioritizing access to FSWs and clients. CONCLUSION: The relative and absolute benefit of ART expansion depends on baseline condom use, ART coverage, and epidemic size. In south India, maximizing FSWs' access to care, followed by maximizing clients' access are the most efficient ways to expand ART for HIV prevention, across baseline intervention context.
Authors: Xiao Zang; Emanuel Krebs; Linwei Wang; Brandon D L Marshall; Reuben Granich; Bruce R Schackman; Julio S G Montaner; Bohdan Nosyk Journal: Pharmacoeconomics Date: 2019-10 Impact factor: 4.981
Authors: Carly A Comins; Sheree R Schwartz; Deliwe R Phetlhu; Vijayanand Guddera; Katherine Young; Jason E Farley; Nora West; Lauren Parmley; Elvin Geng; Chris Beyrer; David Dowdy; Sharmistha Mishra; Harry Hausler; Stefan Baral Journal: Res Nurs Health Date: 2019-01-15 Impact factor: 2.228
Authors: Sharmistha Mishra; Marie-Claude Boily; Sheree Schwartz; Chris Beyrer; James F Blanchard; Stephen Moses; Delivette Castor; Nancy Phaswana-Mafuya; Peter Vickerman; Fatou Drame; Michel Alary; Stefan D Baral Journal: Ann Epidemiol Date: 2016-06-15 Impact factor: 3.797
Authors: Nittaya Phanuphak; Ying-Ru Lo; Yiming Shao; Sunil Suhas Solomon; Robert J O'Connell; Sodsai Tovanabutra; David Chang; Jerome H Kim; Jean Louis Excler Journal: AIDS Res Hum Retroviruses Date: 2015-06-24 Impact factor: 2.205
Authors: William X You; Carly A Comins; Brooke A Jarrett; Katherine Young; Vijayanand Guddera; Deliwe R Phetlhu; Ntambue Mulumba; Mfezi Mcingana; Harry Hausler; Stefan Baral; Sheree Schwartz Journal: Mhealth Date: 2020-04-05
Authors: Emanuel Krebs; Xiao Zang; Benjamin Enns; Jeong E Min; Czarina N Behrends; Carlos Del Rio; Julia C Dombrowski; Daniel J Feaster; Kelly A Gebo; Matthew Golden; Brandon D L Marshall; Lisa R Metsch; Bruce R Schackman; Steven Shoptaw; Steffanie A Strathdee; Bohdan Nosyk Journal: AIDS Date: 2020-03-01 Impact factor: 4.632